Prediction of intestinal permeability

Sietsema, 1989, The absolute oral bioavailability of selected drugs, Int. J. Clin. Pharmacol. Ther. Toxicol., 27, 179 Rowland, 1995 Fleischer, 1999, Drug, meal, and formulation interactions influencing drug absorption after oral administration, Clin. Pharmacokinet., 36, 233, 10.2165/00003088-199936030-00004 Singh, 1999, Effects of food on clinical pharmacokinetics, Clin. Pharmacokinet., 37, 213, 10.2165/00003088-199937030-00003 Chan, 1996, Physicochemical and drug-delivery considerations for oral drug bioavailability, Drug Discov. Today, 1, 461, 10.1016/1359-6446(96)10039-8 Navia, 1996, Design principles for orally bioavailable drugs, Drug Discov. Today, 1, 179, 10.1016/1359-6446(96)10020-9 Conradi, 1996, Physico-chemical and biological factors that influence a drug’s cellular permeability by passive diffusion, Methods Princ. Med. Chem., 4, 233, 10.1002/9783527614998.ch14 Camenisch, 1996, Review of theoretical passive drug absorption models: historical background, recent developments and limitations, Pharm. Acta Helv., 71, 309, 10.1016/S0031-6865(96)00031-3 Kararli, 1989, Gastrointestinal absorption of drugs, Crit. Rev. Ther. Drug Carrier Syst., 6, 39 Singer, 1972, The fluid mosaic model of the structure of cell membranes, Science, 175, 720, 10.1126/science.175.4023.720 Lennernäs, 1997, Human jejunal effective permeability and its correlation with preclinical drug absorption models, J. Pharm. Pharmacol., 49, 627, 10.1111/j.2042-7158.1997.tb06084.x Leo, 1971, Partition coefficients and their uses, Chem. Rev., 71, 525, 10.1021/cr60274a001 Hansch, 1972, Linear relationships between lipophilic character and biological activity of drugs, J. Pharm. Sci., 61, 1, 10.1002/jps.2600610102 Hansch, 1973, Lipophilic character and biological activity of drugs. II. Parabolic case, J. Pharm. Sci., 62, 1, 10.1002/jps.2600620102 Mannhold, 1998, Multivariate analysis of experimental and computational descriptors of molecular lipophilicity, J. Comput. Aided Mol. Des., 12, 573, 10.1023/A:1008060415622 Carrupt, 1997, Computational approaches to lipophilicity: Methods and applications, Vol. 11, pp. 241 Leo, 2000, Calculating log P(oct) with no missing fragments; The problem of estimating new interaction parameters, Perspect. Drug Discov. Des., 18, 19, 10.1023/A:1008739110753 Ghose, 1998, Prediction of hydrophobic (lipophilic) properties of small organic molecules using fragmental methods: An analysis of ALOGP and CLOGP methods, J. Phys. Chem. A, 102, 3762, 10.1021/jp980230o Martin, 1981, A practitioner’s perspective of the role of quantitative structure–activity analysis in medicinal chemistry, J. Med. Chem., 24, 229, 10.1021/jm00135a001 Gobas, 1988, A novel method for measuring membrane–water partition coefficients of hydrophobic organic chemicals: comparison with 1-octanol–water partitioning, J. Pharm. Sci., 77, 265, 10.1002/jps.2600770317 Dearden, 1990, Molecular structure and drug transport, 375 Wils, 1994, High lipophilicity decreases drug transport across intestinal epithelial cells, J. Pharmacol. Exp. Ther., 269, 654 Wright, 1969, Patterns of non-electrolyte permeability, Proc. R. Soc. B, 172, 227, 10.1098/rspb.1969.0021 Diamond, 1969, Molecular forces governing non-electrolyte permeation through cell membranes, Proc. R. Soc. B, 172, 273, 10.1098/rspb.1969.0022 Camenisch, 1998, Shape of membrane permeability–lipophilicity curves: extension of theoretical models with an aqueous pore pathway, Eur. J. Pharm. Sci., 6, 321, 10.1016/S0928-0987(98)00033-5 Palm, 1999, Effect of molecular charge on intestinal epithelial drug transport: pH-dependent transport of cationic drugs, J. Pharmacol. Exp. Ther., 291, 435 Krämer, 1999, Absorption prediction from physicochemical parameters, Pharmaceutical Science and Technology Today, 2, 373, 10.1016/S1461-5347(99)00188-1 Clark, 2000, Computational methods for the prediction of ‘drug-likeness’, Drug Discov. Today, 5, 49, 10.1016/S1359-6446(99)01451-8 van de Waterbeemd, 2001, Property-based design: optimization of drug absorption and pharmacokinetics, J. Med. Chem., 44, 1313, 10.1021/jm000407e van de Waterbeemd, 2000, Intestinal permeability: prediction from theory, Drugs Pharm. Sci., 106, 31 Stenberg, 2000, Virtual screening of intestinal drug permeability, J. Controlled Release, 65, 231, 10.1016/S0168-3659(99)00239-4 Clark, 2001, Prediction of intestinal absorption and blood–brain barrier penetration by computational methods, Combin. Chem. High Throughput Screen., 4, 477, 10.2174/1386207013330850 Lipinski, 1997, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Deliv. Rev., 23, 3, 10.1016/S0169-409X(96)00423-1 Ghose, 1999, A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases, J. Comb. Chem., 1, 55, 10.1021/cc9800071 Oprea, 2000, Property distribution of drug-related chemical databases, J. Comput. Aided Mol. Des., 14, 251, 10.1023/A:1008130001697 Palm, 1997, Polar molecular surface properties predict the intestinal absorption of drugs in humans, Pharm. Res., 14, 568, 10.1023/A:1012188625088 Palm, 1996, Correlation of drug absorption with molecular surface properties, J. Pharm. Sci., 85, 32, 10.1021/js950285r Palm, 1998, Evaluation of dynamic polar molecular surface area as predictor of drug absorption: Comparison with other computational and experimental predictors, J. Med. Chem., 41, 5382, 10.1021/jm980313t Stenberg, 2001, Experimental and computational screening models for the prediction of intestinal drug absorption, J. Med. Chem., 44, 1927, 10.1021/jm001101a Clark, 1999, Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption, J. Pharm. Sci., 88, 807, 10.1021/js9804011 Kelder, 1999, Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs, Pharm. Res., 16, 1514, 10.1023/A:1015040217741 Stenberg, 1999, Prediction of membrane permeability to peptides from calculated dynamic molecular surface properties, Pharm. Res., 16, 205, 10.1023/A:1018816122458 Papageorgiou, 2001, Cell permeability as a parameter for lead generation in the protein kinase inhibition field, Biorg. Med. Chem. Lett., 11, 1549, 10.1016/S0960-894X(01)00022-1 Österberg, 2000, Prediction of polar surface area and drug transport processes using simple parameters and PLS statistics, J. Chem. Inf. Comput. Sci., 40, 1408, 10.1021/ci000065l Norinder, 2001, Theoretical calculation and prediction of drug transport processes using simple parameters and partial least squares projections to latent structures (PLS) statistics. The use of electrotopological state indices, J. Pharm. Sci., 90, 1076, 10.1002/jps.1061 Cheng, 2002, Computation of the physiochemical properties and data mining of large molecular collections, J. Comput. Chem., 23, 172, 10.1002/jcc.1164 Ertl, 2000, Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties, J. Med. Chem., 43, 3714, 10.1021/jm000942e Labute, 2000, A widely applicable set of descriptors, J. Mol. Graph. Model., 18, 464, 10.1016/S1093-3263(00)00068-1 Abraham, 2001, Hydrogen bond structural group constants, J. Org. Chem., 66, 3484, 10.1021/jo001765s Camenisch, 1998, Estimation of permeability by passive diffusion through Caco-2 cell monolayers using drugs’ lipophilicity and molecular weight, Eur. J. Pharm. Sci., 6, 313, 10.1016/S0928-0987(97)10019-7 van de Waterbeemd, 1996, Estimation of Caco-2 cell permeability using calculated molecular descriptors, Quant. Struct.-Act. Relat., 15, 480, 10.1002/qsar.19960150604 Norinder, 1997, Theoretical calculation and prediction of Caco-2 cell permeability using MolSurf parametrization and PLS statistics, Pharm. Res., 14, 1786, 10.1023/A:1012196216736 Norinder, 1999, Theoretical calculation and prediction of intestinal absorption of drugs in humans using MolSurf parametrization and PLS statistics, Eur. J. Pharm. Sci., 8, 49, 10.1016/S0928-0987(98)00059-1 Wessel, 1998, Prediction of human intestinal absorption of drug compounds from molecular structure, J. Chem. Inf. Comput. Sci., 38, 726, 10.1021/ci980029a Raevsky, 2000, Quantitative estimation of drug absorption in humans for passively transported compounds on the basis of their physico-chemical parameters, Quant. Struct.-Act. Relat., 19, 366, 10.1002/1521-3838(200010)19:4<366::AID-QSAR366>3.0.CO;2-E Bravi, 2000, Application of MS-WHIM descriptors: 3. Prediction of molecular properties, Quant. Struct.-Act. Relat., 19, 39, 10.1002/(SICI)1521-3838(200002)19:1<39::AID-QSAR39>3.0.CO;2-N Segarra, 1999, Prediction of drug permeability based on GRID calculations, Quant. Struct.-Act. Relat., 18, 474, 10.1002/(SICI)1521-3838(199911)18:5<474::AID-QSAR474>3.0.CO;2-N Cruciani, 2000, Molecular fields in quantitative structure-permeation relationships: the VolSurf approach, J. Mol. Struct. Theochem., 503, 17, 10.1016/S0166-1280(99)00360-7 Cruciani, 2000, VolSurf: a new tool for the pharmacokinetic optimization of lead compounds, Eur. J. Pharm. Sci., 11, S29, 10.1016/S0928-0987(00)00162-7 Gancia, 2001, Theoretical hydrogen bonding parameters for drug design, J. Mol. Graph. Model., 19, 349, 10.1016/S1093-3263(00)00084-X Österberg, 2001, Prediction of drug transport processes using simple parameters and PLS statistics—The use of ACD/logP and ACD/ChemSketch descriptors, Eur. J. Pharm. Sci., 12, 327, 10.1016/S0928-0987(00)00189-5 Oprea, 1999, Toward minimalistic modeling of oral drug absorption, J. Mol. Graph. Model., 17, 261, 10.1016/S1093-3263(99)00034-0 Egan, 2000, Prediction of drug absorption using multivariate statistics, J. Med. Chem., 43, 3867, 10.1021/jm000292e Zhao, 2001, Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure–activity relationship (QSAR) with the Abraham descriptors, J. Pharm. Sci., 90, 749, 10.1002/jps.1031 Rencher, 1995 Ren, 2000, Caco-2 cell permeability versus human gastrointestinal absorption: QSPR analysis, Prog. Drug Res., 54, 1, 10.1007/978-3-0348-8391-7_1 Alifrangis, 2000, Structure–property model for membrane partitioning of oligopeptides, J. Med. Chem., 43, 103, 10.1021/jm9910932 Winiwarter, 1998, Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach, J. Med. Chem., 41, 4939, 10.1021/jm9810102 Tarbit, 1998, High-throughput approaches for evaluating absorption, distribution, metabolism, and excretion properties of lead compounds, Curr. Opin. Chem. Biol., 2, 411, 10.1016/S1367-5931(98)80017-3 Cohen, 1998 I.S. Krull, Guest Editorial—Reproducibility, reproducibility, and reproducibility, Am. Lab. (Nov 2000) 7–8. Box, 1978 Lewis, 1999 Artursson, 1991, Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells, Biochem. Biophys. Res. Commun., 175, 880, 10.1016/0006-291X(91)91647-U Artursson, 1996, Caco-2 monolayers in experimental and theoretical predictions of drug transport, Adv. Drug Deliv. Rev., 22, 67, 10.1016/S0169-409X(96)00415-2 Stewart, 1997, Discrimination between drug candidates using models for evaluation of intestinal absorption, Adv. Drug Deliv. Rev., 23, 27, 10.1016/S0169-409X(96)00424-3 Gan, 1997, Applications of the Caco-2 model in the design and development of orally active drugs: elucidation of biochemical and physical barriers posed by the intestinal epithelium, Adv. Drug Deliv. Rev., 23, 77, 10.1016/S0169-409X(96)00427-9 Barthe, 1999, Gastrointestinal absorption of drugs: methods and studies, Fundam. Clin. Pharmacol., 13, 154, 10.1111/j.1472-8206.1999.tb00334.x Stewart, 2000, Ex vivo approaches to predicting oral pharmacokinetics in humans, Annu. Rep. Med. Chem., 35, 299, 10.1016/S0065-7743(00)35028-X Balimane, 2000, Current methodologies used for the evaluation of intestinal permeability and absorption, J. Pharmacol. Toxicol. Methods, 44, 301, 10.1016/S1056-8719(00)00113-1 Tukker, 2000, In vitro methods for the assessment of permeability, Drugs Pharm. Sci., 106, 51 J. Gao, E.D. Hugger, M.S. Beck-Westermeyer, R.T. Borchardt, Estimating intestinal mucosal permeation of compounds using Caco-2 cell monolayers, in: S.J. Enna, M. Williams, J.W. Ferkany, T. Kenakin, R.E. Porsolt (Eds.), Current Protocols in Pharmacology, Wiley–VCH, New York, 1998, Suppl. 8, pp. 7.2.1–7.2.23. Irvine, 1999, MDCK (Madin-Darby canine kidney) cells: a tool for membrane permeability screening, J. Pharm. Sci., 88, 28, 10.1021/js9803205 Tavelin, 1999, A conditionally immortalized epithelial cell line for studies of intestinal drug transport, J. Pharmacol. Exp. Ther., 290, 1212 Collett, 1996, Comparison of HT29-18-C1 and Caco-2 cell lines as models for studying intestinal paracellular drug absorption, Pharm. Res., 13, 216, 10.1023/A:1016082829111 Yazdanian, 1998, Correlating partitioning and Caco-2 cell permeability of structurally diverse small molecular weight compounds, Pharm. Res., 15, 1490, 10.1023/A:1011930411574 Chiou, 1998, Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats, Pharm. Res., 15, 1792, 10.1023/A:1011981317451 Yee, 1997, In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestine) absorption in man—fact or myth, Pharm. Res., 14, 763, 10.1023/A:1012102522787 Rubas, 1993, Comparison of the permeability characteristics of a human colonic epithelial (Caco-2) cell line to colon of rabbit, monkey, and dog intestine and human drug absorption, Pharm. Res., 10, 113, 10.1023/A:1018937416447 Yamashita, 2000, Optimized conditions for the prediction of intestinal drug permeability using Caco-2 cells, Eur. J. Pharm. Sci., 10, 195, 10.1016/S0928-0987(00)00076-2 Liang, 2000, Evaluation of an accelerated Caco-2 cell permeability model, J. Pharm. Sci., 89, 336, 10.1002/(SICI)1520-6017(200003)89:3<336::AID-JPS5>3.0.CO;2-M Lipinski, 2000, Drug-like properties and the causes of poor solubility and poor permeability, J. Pharmacol. Toxicol. Methods, 44, 235, 10.1016/S1056-8719(00)00107-6 C.A. Lipinski, Avoiding investment in doomed drugs—is poor solubility an industry wide problem? Curr. Drug Discov. (April 2001) 17–19. Saha, 2000, Effect of solubilizing excipients on permeation of poorly water-soluble compounds across Caco-2 cell monolayers, Eur. J. Pharm. Biopharm., 50, 403, 10.1016/S0939-6411(00)00113-2 Johnson, 1996, Guidance in the setting of drug particle size specifications to minimize variability in absorption, Pharm. Res., 13, 1795, 10.1023/A:1016068705255 Tsuji, 1996, Carrier-mediated intestinal transport of drugs, Pharm. Res., 13, 963, 10.1023/A:1016086003070 Doring, 1998, Minimal molecular determinants of substrates for recognition by the intestinal peptide transporter, J. Biol. Chem., 273, 23211, 10.1074/jbc.273.36.23211 Borst, 2000, A family of drug transporters: The multidrug resistance-associated proteins, J. Natl. Cancer Inst., 92, 1295, 10.1093/jnci/92.16.1295 Borst, 1999, The multidrug resistance protein family, Biochim. Biophys. Acta, 1461, 347, 10.1016/S0005-2736(99)00167-4 Suzuki, 2000, Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine, Eur. J. Pharm. Sci., 12, 3, 10.1016/S0928-0987(00)00178-0 Zhang, 2001, The gut as a barrier to drug absorption—Combined role of cytochrome P450 3A and P-glycoprotein, Clin. Pharmacokinet., 40, 159, 10.2165/00003088-200140030-00002 Seelig, 1998, A general pattern for substrate recognition by P-glycoprotein, Eur. J. Biochem., 251, 252, 10.1046/j.1432-1327.1998.2510252.x Seelig, 2000, Structure–activity relationship of P-glycoprotein substrates and modifiers, Eur. J. Pharm. Sci., 12, 31, 10.1016/S0928-0987(00)00177-9 Seelig, 2000, Substrate recognition by P-glycoprotein and the multidrug resistance-associated protein MRP1: a comparison, Int. J. Clin. Pharmacol. Ther., 38, 111, 10.5414/CPP38111 Doppenschmitt, 1999, Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein, J. Pharm. Sci., 88, 1067, 10.1021/js980378j Westphal, 2000, Oral bioavailability of digoxin is enhanced by talinolol: Evidence for involvement intestinal p-glycoprotein, Clin. Pharmacol. Ther., 68, 6, 10.1067/mcp.2000.107579 Paine, 1997, Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism, J. Pharmacol. Exp. Ther., 283, 1552 Wacher, 1998, Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics, J. Pharm. Sci., 87, 1322, 10.1021/js980082d Kansy, 1998, Physicochemical high throughput screening: Parallel artificial membrane permeation assay in the description of passive absorption processes, J. Med. Chem., 41, 1007, 10.1021/jm970530e Stewart, 1998, Use of immobilized artificial membrane chromatography for drug transport applications, J. Pharm. Sci., 87, 1471, 10.1021/js980262n Balon, 1999, Drug liposome partitioning as a tool for the prediction of human passive intestinal absorption, Pharm. Res., 16, 882, 10.1023/A:1018882221008 Wohnsland, 2001, High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes, J. Med. Chem., 44, 923, 10.1021/jm001020e Loidl-Stahlhofen, 2001, Solid-supported lipid membranes as a tool for determination of membrane affinity: High-throughput screening of a physicochemical parameter, J. Pharm. Sci., 90, 599, 10.1002/1520-6017(200105)90:5<599::AID-JPS1016>3.0.CO;2-N Pontier, 2001, HT29-MTX and Caco-2/Tc7 monolayers as predictive models for human intestinal absorption: role of the mucus layer, J. Pharm. Sci., 90, 1608, 10.1002/jps.1111 Barnett, 1994 Rousseeuw, 1987 Rousseeuw, 1990, J. Am. Stat. Assoc., 85, 633, 10.2307/2289995 Egan, 1998, Outlier detection in multivariate analytical chemical data, Anal. Chem., 70, 2372, 10.1021/ac970763d De Maesschalck, 2000, The Mahalanobis distance, Chemometr. Intell. Lab. Syst., 50, 1, 10.1016/S0169-7439(99)00047-7 Hoaglin, 1978, The Hat matrix in regression and ANOVA, Am. Stat., 32, 17, 10.2307/2683469 Pickett, 2000, Enhancing the hit-to-lead properties of lead optimization libraries, J. Chem. Inf. Comput. Sci., 40, 263, 10.1021/ci990261w Appell, 2001, Combinatorial chemistry and high throughput screening in drug discovery and development, pp. 35